NDC 50268-427

Imatinib Mesylate

Imatinib Mesylate

Imatinib Mesylate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Avpak. The primary component is Imatinib Mesylate.

Product ID50268-427_6c44c643-8dfd-6494-e053-2a91aa0adc57
NDC50268-427
Product TypeHuman Prescription Drug
Proprietary NameImatinib Mesylate
Generic NameImatinib Mesylate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2017-08-24
Marketing CategoryANDA / ANDA
Application NumberANDA079179
Labeler NameAvPAK
Substance NameIMATINIB MESYLATE
Active Ingredient Strength400 mg/1
Pharm ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50268-427-12

20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-427-12) > 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-427-11)
Marketing Start Date2017-08-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50268-427-12 [50268042712]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-08-24

NDC 50268-427-11 [50268042711]

Imatinib Mesylate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA079179
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-08-24

Drug Details

Active Ingredients

IngredientStrength
IMATINIB MESYLATE400 mg/1

OpenFDA Data

SPL SET ID:1c1aa80f-02f2-4338-aff2-30fbc84ac2e5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 403878
  • 403879
  • Pharmacological Class

    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]
    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]

    Medicade Reported Pricing

    50268042712 IMATINIB MESYLATE 400 MG TAB

    Pricing Unit: EA | Drug Type:

    50268042711 IMATINIB MESYLATE 400 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Imatinib Mesylate" or generic name "Imatinib Mesylate"

    NDCBrand NameGeneric Name
    0054-0248Imatinib MesylateImatinib Mesylate
    0054-0249Imatinib MesylateImatinib Mesylate
    0093-7629Imatinib MesylateImatinib Mesylate
    0093-7630Imatinib MesylateImatinib Mesylate
    0378-2245Imatinib Mesylateimatinib
    0378-2246Imatinib Mesylateimatinib
    0904-6621Imatinib MesylateImatinib Mesylate
    67877-634Imatinib mesylateImatinib mesylate
    67877-633Imatinib mesylateImatinib mesylate
    72485-202Imatinib mesylateImatinib mesylate
    0904-6901Imatinib MesylateImatinib Mesylate
    16714-704imatinib mesylateimatinib mesylate
    16714-705imatinib mesylateimatinib mesylate
    42292-044Imatinib MesylateImatinib Mesylate
    42292-043Imatinib MesylateImatinib Mesylate
    47335-472imatinib mesylateimatinib mesylate
    47335-475imatinib mesylateimatinib mesylate
    50268-426Imatinib MesylateImatinib Mesylate
    50268-427Imatinib MesylateImatinib Mesylate
    51991-376IMATINIB MESYLATEIMATINIB MESYLATE
    51991-377IMATINIB MESYLATEIMATINIB MESYLATE
    60429-926Imatinib MesylateImatinib Mesylate
    60505-2900Imatinib MesylateImatinib Mesylate
    60429-925Imatinib MesylateImatinib Mesylate
    60687-203Imatinib MesylateImatinib Mesylate
    60505-2901Imatinib MesylateImatinib Mesylate
    60687-192Imatinib MesylateImatinib Mesylate
    64679-794Imatinib MesylateImatinib Mesylate
    64679-793Imatinib MesylateImatinib Mesylate
    65162-795Imatinib MesylateImatinib Mesylate
    65162-794Imatinib MesylateImatinib Mesylate
    68180-390IMATINIB MESYLATEIMATINIB MESYLATE
    68180-391IMATINIB MESYLATEIMATINIB MESYLATE
    51407-270Imatinib MesylateImatinib Mesylate
    51407-269Imatinib MesylateImatinib Mesylate
    72606-556Imatinib mesylateImatinib mesylate
    72606-557Imatinib mesylateImatinib mesylate
    0078-0401Gleevecimatinib mesylate
    0078-0649Gleevecimatinib mesylate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.